Search results
Covid Vaccine Side Effects: 4 Takeaways From Our Investigation
New York Times· 1 day agoThousands of Americans believe they experienced rare but seriousside effects. Apoorva Mandavilli...
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
Motley Fool via Yahoo Finance· 29 minutes agoThe side effects were so bad that Pfizer opted not to advance the twice-daily danuglipron into...
Thousands Believe Covid Vaccines Harmed Them. Is Anyone Listening?
New York Times· 1 day agoZimmerman, who believes her injury is due to a contaminated vaccine batch. The Covid vaccines, a...
Q&A: AstraZeneca's COVID-19 vaccine and blood clots—what you need to know
Medical Xpress· 3 days agoside effect reduces its legal impact," says Richard Daynard, university distinguished professor of...
Safe and Effective? The New York Times Revisits the COVID Jab. - The American Spectator | USA News...
American Spectator· 8 hours agoIt has taken three years, but the New York Times has finally admitted that maybe, just maybe, there are some serious side effects to COVID vaccines ...
The true tragedy of the Covid-19 vaccines
Daily Telegraph· 3 days agoIndeed, some public health officials exaggerated the benefits and underplayed some of the risks. Thrombosis caused by the AstraZeneca vaccine and...
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Zacks via Yahoo Finance· 5 days agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
The images that show the two sides of AstraZeneca’s vaccine ‘miracle’
The Telegraph via Yahoo Finance· 4 days agoJamie Scott is nothing if not a fighter. He must be to have survived a reaction to his Covid-19 ...
We May Be Facing an Epidemic of This Brain Disease
Mercola· 5 days agoAccording to mounting data, one of the more serious side effects of the COVID mRNA jabs appears to be dementia, and worse yet, this previously untransmissible ...
Pfizer’s 44% Decline In Profits Still Tops Estimates—Stock Bounces From Decade Low
Forbes· 3 days agoPfizer comfortably beat expectations in its quarterly earnings report Wednesday morning, as the...